FDA allows Zyn pouches to be marketed as less harmful than cigarettes
The agency said 20 Zyn products can carry a lower-risk claim after finding that switching from cigarettes may reduce several major disease risks.
- On Tuesday, the Food and Drug Administration authorized Philip Morris-owned Zyn nicotine pouches to be marketed as posing "lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis" than cigarettes.
- This decision follows heavy lobbying from tobacco companies for a clearer authorization process, marking the first time the FDA granted modified-risk status to nicotine pouches following robust scientific review.
- Extensive data showed a majority of adult users reduced cigarette consumption after starting Zyn, with over half reporting no cigarette use in the past 30 days.
- The American Lung Association called the move "appalling", expressing deep concern that flavored nicotine pouches attract youth and are not approved as products to help people quit.
- Swedish Match USA must monitor consumer risk perceptions for five years, as regulators may revoke the modified-risk orders if evidence shows significant increases in youth uptake.
61 Articles
61 Articles
Child psychologist breaks down the risks of ZYN and other nicotine pouches for young people
The Food and Drug Administration now allows ZYN nicotine pouches to be marketed as less harmful than cigarettes. Child psychologist Bonnie Halpern-Felsher joins "The Daily Report" to discuss the risks.
Win for Zyn nicotine pouches
US regulators allowed Philip Morris to advertise its Zyn oral nicotine pouches as less harmful than cigarettes. The decision is a marketing win for the tobacco giant, which like other manufacturers is investing in smoke-free products. Tobacco replacements, such as nicotine pouches or vapes, are vastly less deadly than smoking — a low bar to clear, since smoking is extraordinarily deadly — and help smokers quit, according to a UK government revie…
The Daily Caller
Restoring LibertyWhat The FDA's Latest Ruling Could Mean For Future Of Nicotine Pouches
The Food and Drug Administration announced Tuesday that it will now allow certain nicotine pouches to be marketed as posing fewer health risks than cigarettes.
'Less harmful to health than cigarettes', but controversy breaks out
ZYNdicated: FDA gives nicotine pouch giant a big break
Many people have turned away from cigarettes in recent years, opting for "healthier," smokeless alternatives. And now the Food and Drug Administration has effectively backed up the claim by changing its regulations — for a crowd-favorite brand, no less.'Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.'On Tuesday, the FDA updated its regulations of ZYN…
Coverage Details
Bias Distribution
- 58% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
